Recent News

• 03.10.2025 - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025
• 03.05.2025 - Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering
• 03.04.2025 - Lucid Diagnostics Announces $15.3 Million Registered Direct Offering
• 02.27.2025 - Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD
• 02.25.2025 - Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Recent Filings

• 03.05.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 03.05.2025 - 8-K Current report
• 03.05.2025 - EX-99.1 EX-99.1
• 03.04.2025 - 8-K Current report
• 03.04.2025 - 8-K Current report
• 03.04.2025 - EX-99.1 EX-99.1
• 02.25.2025 - 8-K Current report
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities